A systems approach to understand antigen presentation and the immune response

Methods in Molecular Biology

Volumn 1394, Issue , 2016, Pages 189-209

  Dudek, Nadine L ^a   Croft, Nathan P ^a   Schittenhelm, Ralf B ^a   Ramarathinam, Sri H ^a   Purcell, Anthony W ^a  

^a NONE

Author keywords

Antigen presentation; Human leukocyte antigens; Major histocompatibility complex; Mass spectrometry; Peptide ligands

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEOME; ANTIGEN;

ANTIGEN PRESENTATION; CELL LYSATE; IMMUNE RESPONSE; IMMUNOAFFINITY CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TANDEM MASS SPECTROMETRY; AFFINITY CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNITY; IMMUNOLOGY; ISOLATION AND PURIFICATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MASS SPECTROMETRY; PHYSIOLOGY; PROCEDURES; PROTEOMICS; SYSTEMS BIOLOGY;

ANTIGEN PRESENTATION; ANTIGENS; CHROMATOGRAPHY, AFFINITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; IMMUNE SYSTEM PHENOMENA; IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MASS SPECTROMETRY; PROTEOMICS; SYSTEMS BIOLOGY;

EID: 84951730846     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-3341-9_14     Document Type: Chapter

References (45)

1. Madden DR (1995) The three-dimensional structure of peptide-MHC complexes. Annu Rev Immunol 15:587-622
2. Stern LJ, Brown JH, Jardetzky TS et al (1994) Crystal structure of the human class II MHC protein HLA-DR1 complexed with an infl uenza virus peptide. Nature 368(6468): 215-221
3. Fremont DH, Hendrickson WA, Marrack P et al (1996) Structures of an MHC class II molecule with covalently bound single peptides. Science 272(5264):1001-1004
4. Garcia KC, Teyton L, Wilson IA (1999) Structural basis of T cell recognition. Annu Rev Immunol 17:369-397
5. Falk K, Rötzschke O, Deres K et al (1991) Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast. J Exp Med 174:425-434
6. Sijts AJ, Neisig A, Neefjes J et al (1996) Two Listeria monocytogenes CTL epitopes are processed from the same antigen with different efficiencies. J Immunol 156(2):683-692
7. Rotzschke O, Falk K, Deres K et al (1990) Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature 348(6298):252-254
8. Storkus WJ, Zeh HJ, Maeurer MJ et al (1993) Identification of human melanoma peptides recognized by class I restricted tumor infiltrating T lymphocytes. J Immunol 151(7): 3719-3727
9. Storkus WJ, Zeh HJ, Salter RD et al (1993) Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution. J Immunother 14(2): 94-103
10. Falk K, Rötzschke O, Stevanovic S et al (1991) Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290-296
11. Rammensee HG, Falk K, Rotzschke O (1993) Peptides naturally presented by MHC class I molecules. Annu Rev Immunol 11:213-244
12. Scull KE, Dudek NL, Corbett AJ et al (2012) Secreted HLA recapitulates the immunopeptidome and allows in-depth coverage of HLA A*02:01 ligands. Mol Immunol 51(2):136-142
13. Illing PT, Vivian JP, Dudek NL et al (2012) Immune self-reactivity triggered by drugmodified HLA-peptide repertoire. Nature 486(7404):554-558
14. Dudek NL, Tan CT, Gorasia DG et al (2012) Constitutive and infl ammatory immunopeptidome of pancreatic beta-cells. Diabetes 61(11):3018-3025
15. Urban RG, Chicz RM, Lane WS et al (1994) A subset of HLA-B27 molecules contains peptides much longer than nonamers. Proc Natl Acad Sci U S A 91(4):1534-1538
16. Purcell AW, Kelly AJ, Peh CA et al (2000) Endogenous and exogenous factors contributing to the surface expression of HLA B27 on mutant APC. Hum Immunol 61(2):120-130
17. Storkus WJ, Howell DN, Salter RD et al (1987) NK susceptibility varies inversely with target cell class I HLA antigen expression. J Immunol 138(6):1657-1659
18. Macdonald WA, Purcell AW, Mifsud NA et al (2003) A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition. J Exp Med 198(5):679-691
19. Zernich D, Purcell AW, Macdonald WA et al (2004) Natural HLA class I polymorphism controls the pathway of antigen presentation and susceptibility to viral evasion. J Exp Med 200(1):13-24
20. Scally SW, Petersen J, Law SC et al (2013) A molecular basis for the association of the HLADRB1 locus, citrullination, and rheumatoid arthritis. J Exp Med 210(12):2569-2582
21. Ringrose JH, Yard BA, Muijsers A et al (1996) Comparison of peptides eluted from the groove of HLA-B27 from Salmonella infected and non-infected cells. Clin Rheumatol 15 Suppl 1:74-78
22. van Els CA, Herberts CA, van der Heeft E et al (2000) A single naturally processedmeasles virus peptide fully dominates the HLA- A*0201-associated peptide display and is mutated at its anchor position in persistent viral strains. Eur J Immunol 30(4):1172-1181
23. Nepom BS, Nepom GT, Coleman M et al (1996) Critical contribution of beta chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules. Proc Natl Acad Sci U S A 93(14):7202-7206
24. Lampson LA, Levy R (1980) Two populations of Ia-like molecules on a human B cell line. J Immunol 125(1):293-299
25. Gorga JC, Knudsen PJ, Foran JA et al (1986) Immunochemically purified DR antigens in liposomes stimulate xenogeneic cytolytic T cells in secondary in vitro cultures. Cell Immunol 103(1):160-173
26. Watson AJ, DeMars R, Trowbridge IS et al (1983) Detection of a novel human class II HLA antigen. Nature 304(5924):358-361
27. Parham P, Brodsky FM (1981) Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA- A2 and a variant of HLA-A28. Hum Immunol 3(4):277-299
28. Ellis SA, Taylor C, McMichael A (1982) Recognition of HLA-B27 and related antigen by a monoclonal antibody. Hum Immunol 5(1):49-59
29. Schittenhelm RB, Dudek NL, Croft NP et al (2014) A comprehensive analysis of constitutive naturally processed and presented HLAC* 04:01 (Cw4)-specific peptides. Tissue Antigens 83(3):174-179
30. Braud VM, Allan DS, Wilson D et al (1998) TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr Biol 8(1):1-10
31. Thomas R, Apps R, Qi Y et al (2009) HLA-C cell surface expression and control of HIV/ AIDS correlate with a variant upstream of HLA-C. Nat Genet 41(12):1290-1294
32. Hammerling GJ, Rusch E, Tada N et al (1982) Localization of allodeterminants on H-2Kb antigens determined with monoclonal antibodies and H-2 mutant mice. Proc Natl Acad Sci U S A 79(15):4737-4741
33. Straus DS, Stroynowski I, Schiffer SG et al (1985) Expression of hybrid class I genes of the major histocompatibility complex in mouse L cells. Proc Natl Acad Sci U S A 82(18): 6245-6249
34. Ozato K, Sachs DH (1981) Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression. J Immunol 126(1):317-321
35. Kappler JW, Skidmore B, White J et al (1981) Antigen-inducible, H-2-restricted, interleukin- 2- producing T cell hybridomas. Lack of independent antigen and H-2 recognition. J Exp Med 153(5):1198-1214
36. Janeway CA Jr, Conrad PJ, Lerner EA et al (1984) Monoclonal antibodies specific for Ia glycoproteins raised by immunization with activated T cells: possible role of T cellbound Ia antigens as targets of immunoregulatory T cells. J Immunol 132(2):662-667
37. Oi VT, Jones PP, Goding JW et al (1978) Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens. Curr Top Microbiol Immunol 81:115-120
38. Croft NP, Smith SA, Wong YC et al (2013) Kinetics of antigen expression and epitope presentation during virus infection. PLoS Pathog 9(1), e1003129
39. Tan CT, Croft NP, Dudek NL et al (2011) Direct quantitation of MHC-bound peptide epitopes by selected reaction monitoring. Proteomics 11(11):2336-2340
40. Wisniewski JR, Zougman A, Nagaraj N et al (2009) Universal sample preparation method for proteome analysis. Nat Methods 6(5):359-362. doi: 10.1038/nmeth.1322
41. Lange V, Picotti P, Domon B et al (2008) Selected reaction monitoring for quantitative proteomics: a tutorial. Mol Syst Biol 4:222
42. Edwards PA, Smith CM, Neville AM et al (1982) A human-hybridoma system based on a fast-growing mutant of the ARH-77 plasma cell leukemia-derived line. Eur J Immunol 12(8):641-648
43. Alexander J, Payne JA, Murray R et al (1989) Differential transport requirements of HLA and H-2 class I glycoproteins. Immunogenetics 29(6):380-388
44. Nelson CA, Roof RW, McCourt DW et al (1992) Identification of the naturally processed form of hen egg white lysozyme bound to the murine major histocompatibility complex class II molecule I-Ak. Proc Natl Acad Sci U S A 89(16):7380-7383
45. Escher C, Reiter L, MacLean B et al (2012) Using iRT, a normalized retention time for more targeted measurement of peptides. Proteomics 12(8):1111-1121